STK33 and familial pancreatic carcinoma: The results showed that the iron chelator, ferroptosis inhibitor, and glutathione significantly alleviated the inhibitory effects of reduced MACC1-AS1 or STK33 expression on the viability of pancreatic cancer cells (Fig. 4A).